Long-term health-related quality of life and rhythm outcomes of catheter ablation versus antiarrhythmic drugs in patients with atrial fibrillation
HRQoL improvement in long-term did not differ between ablation and AAD groups despite a larger reduction in AF burden after ablation. The results should be interpreted in the light of a high crossover rate in the AAD group.
Authors
- Göran Kennebäck
- Carina Blomström‐Lundqvist (ORCID: https://orcid.org/0000-0003-2806-3903)
- Aigars Rubulis
- Jonas Schwieler (ORCID: https://orcid.org/0009-0005-7393-6242)
- Steen M. Jensen (ORCID: https://orcid.org/0000-0001-5275-2544)
- Victoria Svedung Wettervik (ORCID: https://orcid.org/0000-0002-0305-8043)
- Elena Sciaraffia
- Lennart Bergfeldt (ORCID: https://orcid.org/0000-0002-0161-9388)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Sahlgrenska University Hospital (SE)
- Art Research Centre of the Slovak Academy of Sciences (SK)
- Umeå University (SE)
Publication Details
- Journal
- Heart Rhythm
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1016/j.hrthm.2024.09.044
- Citations
- 9
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.62
Funders
- Medtronic
- Hjärt-Lungfonden
- Vetenskapsrådet